1. Home
  2. FIVE vs MDGL Comparison

FIVE vs MDGL Comparison

Compare FIVE & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Below Inc.

FIVE

Five Below Inc.

HOLD

Current Price

$232.58

Market Cap

12.0B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$521.36

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVE
MDGL
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
12.1B
IPO Year
2012
2005

Fundamental Metrics

Financial Performance
Metric
FIVE
MDGL
Price
$232.58
$521.36
Analyst Decision
Buy
Strong Buy
Analyst Count
20
12
Target Price
$236.00
$674.45
AVG Volume (30 Days)
1.1M
277.0K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
40.65
41.32
EPS
6.47
N/A
Revenue
$4,764,147,000.00
$180,133,000.00
Revenue This Year
$14.44
$58.39
Revenue Next Year
$9.37
$48.55
P/E Ratio
$36.04
N/A
Revenue Growth
22.90
N/A
52 Week Low
$73.92
$265.00
52 Week High
$251.63
$615.00

Technical Indicators

Market Signals
Indicator
FIVE
MDGL
Relative Strength Index (RSI) 53.36 54.17
Support Level $213.25 $503.93
Resistance Level $235.08 $539.17
Average True Range (ATR) 8.64 16.01
MACD 0.01 -3.37
Stochastic Oscillator 52.07 42.85

Price Performance

Historical Comparison
FIVE
MDGL

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: